Penumbra Inc income statement

In fiscal 2025, Penumbra Inc reported revenue of $1.40bn, up 17.5% on the year before, operating income of $189m (a 13.5% margin) and net income of $178m, or $4.52 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Penumbra Inc: income statement, annual
Fiscal year	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Revenue	89	126	186	263	334	445	547	560	748	847	1,059	1,195	1,404	1,560
Cost of revenue	31	43	62	92	117	152	175	222	272	312	376	440	461	500
Gross profit	58	83	124	171	217	293	372	338	475	535	683	755	942	1,061
Research and development	14	16	18	24	32	36	52	90	105	79	84	95	90	95
Selling, general and administrative	45	64	102	148	184	226	273	287	378	450	506	574	663	777
Operating income	−1	3	4	−1	1	−1	48	−39	−8	6	74	9	189	189
Interest expense	—	—	—	—	—	—	—	—	2	2	2	1	1	1
Income before tax	−1	3	4	−1	2	2	50	−38	−11	4	80	21	205	208
Income tax	−5	1	2	−16	−4	−4	3	−19	−13	6	−11	7	27	51
Net income	4	2	2	15	5	7	48	−16	5	−2	91	14	178	157
Diluted EPS	$0.05	−$0.06	$0.08	$0.44	$0.13	$0.18	$1.34	−$0.44	$0.14	−$0.05	$2.32	$0.36	$4.52	$3.97
Diluted shares (average)	20m	14m	14m	33m	35m	36m	36m	36m	38m	38m	39m	39m	39m	40m
EBITDA	−0	4	6	1	5	5	56	−26	9	30	101	33	207	209

US$ millions unless shown otherwise. Fiscal quarters.

Penumbra Inc: income statement, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Revenue	316	324	339	355	385	375	390	410
Cost of revenue	105	108	115	114	123	121	125	130
Gross profit	211	216	224	240	262	253	265	280
Research and development	20	22	23	23	22	22	25	25
Selling, general and administrative	148	153	160	169	181	193	199	204
Operating income	43	40	41	49	59	38	41	51
Interest expense	0	0	0	0	0	0	0	0
Income before tax	44	44	45	52	64	42	46	56
Income tax	11	5	0	6	16	9	11	14
Net income	34	39	45	46	47	33	35	42
Diluted EPS	$0.87	$1.00	$1.15	$1.17	$1.20	$0.82	$0.88	$1.07
EBITDA	47	45	46	51	64	43	47	56

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MMSI vs PEN IART vs PEN HAE vs PEN PEN vs STVN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Penumbra Inc's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Penumbra Inc.